Calcium
Introduction
Calcium is an essential mineral and the most abundant mineral element found in the human body. It plays a fundamental role in a vast array of biological processes, serving primarily as a structural component of bones and teeth. Beyond its structural functions, calcium is critical for muscle contraction, nerve impulse transmission, blood clotting, and the secretion of various hormones and enzymes. The body maintains a precise balance of calcium levels within the blood and tissues through sophisticated homeostatic mechanisms, largely regulated by parathyroid hormone and vitamin D.
Maintaining optimal calcium levels is vital for overall health, as imbalances can lead to significant clinical implications. Insufficient long-term calcium intake or impaired absorption can contribute to conditions such as osteoporosis, characterized by a reduction in bone density and increased fracture risk. Conversely, elevated calcium levels, known as hypercalcemia, can lead to health issues including kidney stone formation, bone pain, and potential cardiovascular complications. In clinical settings, "corrected calcium" is a measure often utilized to estimate the concentration of ionized calcium in the blood, which represents the physiologically active form of the mineral. [1]
Genetic factors contribute to individual variability in calcium metabolism and excretion. Studies indicate a genetic influence on processes such as bone metabolism, calcium excretion, and the regulation of hormones like vitamin D and parathyroid hormone. [2] From a public health perspective, promoting adequate dietary calcium intake is a cornerstone for maintaining bone health throughout life. Understanding both environmental and genetic influences on calcium regulation can offer insights for personalized health strategies.
Methodological and Statistical Constraints
Studies investigating complex traits like calcium levels or calcification are often constrained by their design and statistical power. Many genome-wide association studies (GWAS) utilize SNP arrays with limited coverage, such as 100K chips, which may not capture all genetic variation within a region or specific causal variants, potentially leading to missed associations or an underestimation of genetic contributions. [3] The ability to detect modest genetic effects is also limited by sample size and the extensive multiple testing inherent in GWAS, meaning genuine associations with smaller effect sizes might remain undiscovered. [4] Furthermore, the lack of consistent replication of findings across different studies, often due to variations in study design, power, or the specific SNPs genotyped, suggests that some reported associations may represent false positives and require further validation. [5]
The accuracy of estimated genetic variance explained by SNPs, for traits such as calcium, relies heavily on the initial assumptions about phenotypic variance and heritability, which can introduce uncertainty into the overall interpretation of effect sizes. [6] While rigorous statistical thresholds are necessary to control for false positives in genome-wide analyses, this stringency can inadvertently lead to overlooking true associations, particularly those with subtle effects or those that are sex-specific if only sex-pooled analyses are conducted. [7] Moreover, specific analytical choices, such as focusing exclusively on multivariable models, might obscure important bivariate associations between genetic variants and calcium-related phenotypes. [5]
Generalizability and Phenotypic Assessment Challenges
The generalizability of findings from genetic studies of calcium is a significant limitation, particularly when samples are drawn from specific populations. Results from studies predominantly involving twins, such as adolescent or adult female monozygotic twin cohorts, may not be fully applicable to the broader general population due to potential unique characteristics or ascertainment biases inherent in twin studies. [6] Similarly, volunteer-based cohorts, while valuable, may not represent a truly random sample of the population, introducing participation bias that could affect the observed associations. [6] Many studies are also conducted in ethnically homogeneous populations, predominantly individuals of European descent, which limits the extrapolation of findings to other diverse ethnic groups where genetic architectures and environmental backgrounds may differ, impacting the universal relevance of identified variants. [5]
Phenotypic assessment for calcium-related traits also presents challenges. Modalities used to measure phenotypes like subclinical atherosclerosis often focus on fixed components, such as calcific plaque, rather than dynamic or metabolically active aspects of calcium metabolism, which could provide a more comprehensive understanding. [3] The reliance on proxy markers or existing measurement equations, especially those developed in smaller, selected samples or using different methodologies, may introduce inaccuracies when applied to larger, population-based cohorts. [5] Furthermore, physiological factors can confound phenotypic measurements; for instance, the time of day when blood samples are collected or an individual's menopausal status can influence serum markers, necessitating careful adjustment in study design and interpretation. [6]
Unaccounted Environmental Factors and Genetic Complexity
A crucial limitation in understanding the genetic basis of calcium-related traits is the potential influence of unexamined environmental factors and gene-environment interactions. Genetic variants often do not act in isolation but are modulated by environmental influences such as diet, lifestyle, or other contextual factors. [4] The absence of comprehensive investigations into these gene-environmental interactions can lead to an incomplete picture of how genetic predispositions manifest, potentially obscuring the full impact of identified genetic variants on phenotypes like calcium metabolism or bone health. [4] Moreover, unidentified environmental confounders or lifestyle differences across study populations could either mask true genetic associations or create spurious ones, complicating the accurate interpretation of genetic findings. [3]
Despite the power of GWAS, a significant portion of the heritability for complex traits, including those related to calcium, often remains unexplained, a phenomenon known as "missing heritability." This gap can be attributed to several factors, including the limitations of current SNP arrays, which may not cover all causal variants or entire genes, particularly if they are not in strong linkage disequilibrium with genotyped SNPs. [6] For example, some known functional mutations might be entirely absent from array designs, leaving their effects undetected. Consequently, while GWAS identifies novel genetic associations, there remain substantial knowledge gaps regarding the complete genetic architecture and the intricate biological mechanisms underlying complex calcium-related phenotypes. [7]
Variants
Genetic variations play a crucial role in influencing a wide array of biological processes, including those related to calcium homeostasis and bone health. These variations can affect gene function, protein activity, and cellular pathways, ultimately contributing to individual differences in physiological traits. Research has shown that genetics significantly contributes to bone metabolism, calcium excretion, and the regulation of vitamin D and parathyroid hormone, highlighting the complex interplay of inherited factors in maintaining mineral balance. [2]
Several variants are associated with genes involved in cellular signaling and transcriptional regulation. For instance, variants rs880315 and rs17035646 are located within the CASZ1 gene, which encodes a zinc finger transcription factor. CASZ1 is known for its roles in neurogenesis and tumor suppression, and as a transcription factor, it can broadly regulate the expression of many genes, potentially including those indirectly involved in calcium transport or signaling pathways. The PRDM8 gene, associated with variants like rs12509595 and rs10857147, is a histone methyltransferase, impacting gene expression through chromatin modification. Changes in chromatin structure can alter the transcription of genes critical for bone development and mineral metabolism. Furthermore, the WNT2B gene, with variant rs3790604, is a key component of the Wnt signaling pathway, which is fundamental for bone formation and remodeling. Disruptions in this pathway can lead to altered osteoblast activity and bone mineralization, thereby influencing systemic calcium levels. Similarly, RSPO3, associated with variants rs9375461, rs9398823, and rs1105956, acts as a potent activator of Wnt signaling, further emphasizing its potential indirect role in calcium regulation through bone metabolism. [8]
Other variants influence genes involved in ion transport and metabolic processes critical for cellular function. Variants rs1275988, rs11126666, and rs12476527 are found in the KCNK3 gene, which codes for a potassium channel protein (TASK-1). Potassium channels are essential for maintaining cell membrane potential and excitability, processes that are intimately linked to intracellular calcium signaling in many cell types, including those in bone and kidney that regulate calcium. The NOS3 gene, featuring variant rs3918226, produces nitric oxide synthase 3 (eNOS), an enzyme vital for producing nitric oxide. Nitric oxide plays a significant role in vascular health and also influences bone remodeling by affecting the activity of osteoblasts and osteoclasts, thus indirectly impacting calcium homeostasis. The LSP1 gene, with variants rs569550 and rs562434, encodes an actin-binding protein primarily expressed in leukocytes. While directly involved in cell motility and adhesion, its involvement in immune and inflammatory responses could indirectly affect bone health and calcium balance, as chronic inflammation can impact bone density. [2]
Finally, variants in genes related to detoxification and non-coding RNA also contribute to the genetic landscape influencing health traits. The ALDH2 gene, with variants rs4646776 and rs671, is crucial for detoxifying aldehydes, including acetaldehyde from alcohol metabolism. A common variant, rs671, is well-known for affecting alcohol tolerance. While not directly involved in calcium transport, chronic alcohol consumption, which can be influenced by ALDH2 genotype, is a recognized risk factor for osteoporosis and can disrupt calcium balance. Additionally, variants rs35443, rs35429, and rs2067249 are found in the TBX3-AS1 region, which is an antisense long non-coding RNA that can regulate the TBX3 gene. TBX3 is a transcription factor involved in developmental processes, and its regulation could have broad effects on tissue development, potentially including bone. Pseudogenes like RPL37P11 (associated with rs1275988 through its proximity to KCNK3) and RPS4XP9 (associated with rs9375461, rs9398823, rs1105956 through its proximity to RSPO3) and UBA52P7 (associated with rs35443, rs35429, rs2067249 through its proximity to TBX3-AS1) represent genetic variations that may not encode proteins but can still influence gene expression or chromosome structure, thereby indirectly affecting physiological processes, including those related to calcium metabolism. [8]
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs34408666 rs1801725 rs1979869 |
CASR | educational attainment calcium measurement |
| rs73186030 rs884096 rs4048557 |
CASR - HNRNPA1P23 | blood parathyroid hormone amount calcium measurement cadherin-related family member 1 measurement phosphate measurement level of protocadherin-12 in blood serum |
| rs28384492 rs116555124 rs71329269 |
KPNA1 | calcium measurement blood phosphate measurement |
| rs35009121 rs72788346 rs76544535 |
LINC00709 - HSP90AB7P | calcium measurement |
| rs1260326 rs780094 rs780093 |
GCKR | urate measurement total blood protein measurement serum albumin amount coronary artery calcification lipid measurement |
| rs73858153 rs138048566 rs116140498 |
CD86 - CASR | calcium measurement |
| rs6127099 rs17216707 rs35870583 |
BCAS1 - CYP24A1 | blood parathyroid hormone amount glomerular filtration rate vitamin D amount urate measurement serum creatinine amount, glomerular filtration rate |
| rs838717 rs838718 rs838716 |
DGKD | calcium measurement nephrolithiasis urolithiasis phosphate measurement HbA1c measurement |
| rs11078597 rs62090014 |
MIR22HG | serum albumin amount alkaline phosphatase measurement calcium measurement C-reactive protein measurement sex hormone-binding globulin measurement |
| rs1672991 rs1672992 |
HPN, HPN-AS1 | alkaline phosphatase measurement calcium measurement discoidin, CUB and LCCL domain-containing protein 2 measurement |
Forms and Biological Significance
Calcium is an essential mineral with diverse physiological roles, existing in various forms within the body and environment. In biological systems, it is critical for bone structure, muscle contraction, nerve transmission, and intracellular signaling. Circulating calcium in the blood is often measured as "corrected calcium," which serves as an estimate of ionized calcium, the biologically active form. [1] The regulation of calcium homeostasis is tightly controlled by endocrine factors, including vitamin D and parathyroid hormone, and is closely linked to bone metabolism and kidney function, influencing calcium excretion. [8] Deviations in systemic calcium levels can indicate underlying metabolic or endocrine disorders.
Classification of Arterial Calcification
In the context of cardiovascular health, calcium is primarily discussed in terms of pathological calcification, particularly within arterial walls. This phenomenon is classified based on its location in major arterial territories. The two primary classifications are Coronary Artery Calcification (CAC) and Abdominal Aortic Calcification (AAC). [3] Both CAC and AAC are considered objective measures of subclinical atherosclerosis, indicating the presence and extent of atherosclerotic plaque burden before the manifestation of clinical symptoms. [3] These calcifications reflect chronic inflammatory and degenerative processes within the arterial wall, serving as important prognostic markers for future cardiovascular events.
Measurement and Quantitative Assessment
The assessment of arterial calcification relies on precise imaging and scoring methodologies. Coronary and abdominal aortic calcification are typically measured using multidetector computed tomography (MDCT). [3] A calcified lesion is operationally defined as an area consisting of at least three connected pixels with a CT attenuation value greater than 130 Hounsfield Units (HU), determined using 3D connectivity criteria. [3] The quantitative scoring of these calcifications, such as the modified Agatston Score, involves multiplying the area of a calcified lesion by a weighted CT attenuation score based on the maximal CT attenuation within the lesion. [3] Calibration phantoms containing known concentrations of calcium hydroxyapatite are used to ensure accurate and reproducible measurements across different scans. [3]
Terminology and Clinical Context
Key terminology associated with calcium in a clinical and research setting primarily includes Coronary Artery Calcification (CAC) and Abdominal Aortic Calcification (AAC), which are abbreviations for calcification observed in the coronary arteries and abdominal aorta, respectively. [3] Multidetector Computed Tomography (MDCT) refers to the imaging technology used for their detection and quantification, with Hounsfield Units (HU) being the standardized unit for CT attenuation values. [3] Beyond arterial calcification, "corrected calcium" is a term used in serum biochemistry to provide a more accurate estimate of ionized calcium, particularly when serum albumin levels are abnormal. [1] These terms are crucial for understanding the diagnostic, prognostic, and research implications of calcium in both systemic physiology and cardiovascular disease.
Systemic Calcium Homeostasis and Biochemical Assessment
Calcium levels in the body are maintained through a tightly regulated homeostatic system, with systemic calcium status typically assessed through biochemical measures. Serum corrected calcium serves as an estimate of ionized calcium, a key biomarker for evaluating overall calcium balance. [1] Clinical laboratories, such as the Clinical Biochemistry Unit at the University of Glasgow, establish normal reference ranges for these measures, with a median corrected calcium of 2.34 mmol/L and an interquartile range of 0.15 mmol/L observed in some populations. [1] Deviations from these established ranges can indicate underlying metabolic disturbances or health conditions, guiding further diagnostic investigation.
Inter-individual variation in calcium-related traits, including calcium excretion, is influenced by genetic factors, alongside vitamin D and parathyroid hormone regulation. [2] These variations necessitate careful consideration of individual patient profiles during diagnostic interpretation. While the specific clinical symptoms of calcium imbalance are not detailed in the available research, the precise measurement of corrected calcium is diagnostically significant for identifying potential physiological dysregulation, with normal ranges serving as critical diagnostic benchmarks. [1]
Vascular Calcification and Atherosclerotic Manifestations
Beyond systemic levels, calcium's clinical presentation also includes its pathological deposition within vascular structures, manifesting as subclinical atherosclerosis. Coronary artery calcification (CAC) and abdominal aortic calcification (AAC) are objective phenotypes measured through multidetector computed tomography (MDCT). [3] Calcified lesions are identified as areas of at least three connected pixels with CT attenuation exceeding 130 Hounsfield Units, with a score derived by multiplying the lesion area by a weighted CT attenuation. [3] This method, a modification of the Agatston Score, demonstrates excellent intra- and inter-reader reproducibility, underscoring its reliability as a diagnostic tool. [3]
The presence and extent of CAC and AAC carry significant diagnostic and prognostic value, serving as indicators of cardiovascular disease risk. [3] Studies often adjust for demographic factors such as age and sex when evaluating these calcification phenotypes, recognizing their influence on presentation patterns. [3] For instance, sex-specific and age-adjusted residuals are commonly employed in analyses to account for inter-individual and age-related variability, highlighting the diverse clinical correlations of vascular calcification across different populations. [3] The use of a calibration phantom containing calcium hydroxyapatite ensures consistent measurement of calcium density in these assessments. [3]
Genetic Determinants of Calcium Homeostasis
Calcium levels in the body are significantly influenced by an individual's genetic makeup, with inherited variants contributing to the regulation of calcium homeostasis. Studies indicate a genetic contribution to critical processes such as bone metabolism, the excretion of calcium, and the regulation of vitamin D and parathyroid hormone. [2] These genetic factors can influence how efficiently the body absorbs calcium, stores it in bones, and maintains its concentration in the blood. This reflects a complex polygenic risk architecture rather than simple Mendelian inheritance for typical variations in calcium levels, where the interplay between various genes collectively impacts the overall calcium balance.
Dietary, Lifestyle, and Environmental Factors
Environmental and lifestyle choices play a crucial role in determining calcium levels. Nutritional intake, particularly of vitamins essential for bone health, is paramount; for instance, plasma levels of Vitamin D (25(OH)-D) and Vitamin K (phylloquinone) are directly linked to calcium metabolism. [8] Vitamin K is vital for the carboxylation of osteocalcin, a protein central to bone formation, and its status significantly impacts bone health . [9] Beyond diet, lifestyle factors such as age, sex, body mass index (BMI), smoking, and alcohol use are recognized as important covariates influencing various biomarker traits, which can include corrected calcium levels. [8]
Age, Comorbidities, and Medication Effects
The physiological regulation of calcium can undergo significant changes with age, contributing to variations in its levels throughout life. Advancing age is a recognized factor that influences many biomarker traits, including those related to mineral balance. [8] Furthermore, the presence of comorbidities such as diabetes or prevalent cardiovascular disease (CVD) can impact calcium regulation. [8] Various medications, including those for hypertension (HTN Rx), lipid lowering (lipid lowering Rx), hormone replacement (hormone replacement Rx), and asthma (asthma Rx), are also known to affect physiological parameters and could indirectly or directly influence calcium levels. [8] These factors highlight the complex interplay between an individual's health status, therapeutic interventions, and overall calcium dynamics.
Biological Background of Calcium
Calcium is a vital mineral in the human body, playing indispensable roles in structural integrity, cellular signaling, and numerous physiological processes. Its precise regulation is critical for maintaining overall health, with imbalances leading to a range of pathophysiological conditions. The body maintains tight control over calcium levels through a complex interplay of hormones, proteins, and genetic mechanisms.
Calcium Homeostasis and Regulation
The body tightly regulates calcium levels to ensure its availability for essential functions, a process known as calcium homeostasis. This intricate balance is primarily governed by a sophisticated endocrine system involving key hormones such as parathyroid hormone and vitamin D. These biomolecules coordinate calcium absorption from the digestive tract, its reabsorption in the kidneys, and its mobilization or deposition in bone tissue, thereby maintaining stable concentrations in the blood. [2] Disruptions in these regulatory networks can significantly impact various organ systems, highlighting the systemic importance of maintaining calcium balance.
Calcium in Bone Health and Mineralization
Calcium is predominantly recognized for its role as a fundamental structural component, forming the primary mineral matrix of bones in the form of calcium hydroxyapatite. [3] Bone tissue undergoes continuous remodeling, involving coordinated processes of bone formation and resorption to maintain skeletal integrity and contribute to the body's calcium reservoir. [2] Proteins such as osteocalcin are crucial for bone health, acting as a vitamin K-dependent protein that facilitates the proper mineralization and incorporation of calcium into the bone matrix. [9] The integrity of these molecular and cellular mechanisms is essential for bone strength and the prevention of skeletal disorders.
Calcium and Cardiovascular Health
Beyond its structural and signaling roles, the pathological accumulation of calcium in soft tissues, particularly within the cardiovascular system, represents a significant pathophysiological concern. Coronary artery calcification (CAC) and abdominal aortic calcification (AAC) are established indicators of subclinical atherosclerosis, where calcium deposits accumulate in the walls of major arteries. [3] These calcified lesions, characterized by areas of high CT attenuation, reflect arterial stiffening and the progression of atherosclerotic plaque, contributing to an increased risk of cardiovascular disease. [3] Precise measurement of these calcifications, often performed using specialized imaging techniques and scoring algorithms adapted for multidetector computed tomography, is vital for assessing cardiovascular risk.
Genetic Influences on Calcium Metabolism
Genetic factors contribute substantially to the observed variability in individual calcium metabolism and related physiological traits. Research indicates a significant genetic component influencing processes such as overall bone metabolism and the efficiency with which the body excretes calcium. [2] Furthermore, the intricate regulation of key hormones central to calcium homeostasis, including vitamin D and parathyroid hormone, is also subject to considerable genetic influence. [2] These genetic predispositions can impact the molecular and cellular pathways involved in calcium transport, storage, and signaling, potentially affecting an individual's susceptibility to conditions arising from calcium imbalances.
Calcium Homeostasis and Bone Metabolism
Calcium is a crucial element in bone metabolism, contributing significantly to skeletal structure and dynamic bone remodeling. The body maintains a precise balance of calcium through various physiological processes, including regulated calcium excretion. [2] This intricate metabolic control is essential for ensuring systemic calcium homeostasis and the sustained health of bone tissue.
Hormonal Regulation of Calcium and Bone Health
The systemic regulation of calcium is largely orchestrated by key endocrine factors, notably vitamin D and parathyroid hormone. These hormones play a pivotal role in modulating calcium levels, thereby influencing its distribution, utilization, and excretion, which collectively impact overall bone health. [2] Complementing this hormonal control, proteins like osteocalcin are integral to bone health, with its assessment sometimes linked to vitamin K status, further highlighting the multifaceted regulatory network within bone physiology. [9]
Calcium as a Biomarker for Cardiovascular Risk Stratification
Calcium deposition in arterial walls serves as a critical biomarker for subclinical atherosclerosis, offering significant prognostic value for cardiovascular disease. Coronary artery calcification (CAC) and abdominal aortic calcification (AAC) are quantified using multidetector computed tomography (MDCT) scans, where calcified lesions are defined by specific Hounsfield Units thresholds and 3D connectivity criteria. [3] The Agatston score, adapted for MDCT protocols, provides a quantitative measure by multiplying the calcified lesion area with a weighted CT attenuation score. [3] These measurements, performed with excellent intra- and inter-reader reproducibility, identify high-risk individuals by detecting early, asymptomatic arterial stiffening and plaque burden. [3]
The presence and extent of CAC and AAC are strongly associated with future cardiovascular events and disease progression, making them valuable tools for risk assessment and personalized medicine approaches. Genome-wide association studies have identified several single nucleotide polymorphisms (SNPs) associated with CAC and AAC, such as rs10240716, rs10505346, rs10500724, and rs10488813. [3] These genetic insights can further refine risk stratification, potentially guiding prevention strategies and earlier interventions in genetically predisposed individuals, even before clinical symptoms manifest.
Systemic Calcium Homeostasis and Clinical Monitoring
Beyond arterial calcification, systemic calcium levels are routinely monitored as indicators of overall health and metabolic function. Corrected calcium in serum is a standard biochemical measure, often estimated to reflect ionized calcium, and is typically assessed from nonfasting samples. [1] Maintaining calcium within its normal range (e.g., a median of 2.34 mmol/L with an interquartile range of 0.15 mmol/L) is crucial, as deviations can signal underlying comorbidities or metabolic disturbances. [1]
Genetic factors play a substantial role in regulating calcium metabolism, including calcium excretion, bone metabolism, and the regulation of vitamin D and parathyroid hormone. [8] This genetic contribution highlights the complex interplay between diet, environment, and individual predisposition in maintaining calcium balance. Monitoring serum calcium levels is thus essential for diagnosing and managing conditions related to bone health, renal function, and endocrine disorders, providing critical insights for patient care and therapeutic adjustments.
Therapeutic Interventions Targeting Calcium Pathways
Calcium pathways are targeted in various therapeutic strategies, particularly in the management of cardiovascular conditions like hypertension. Calcium antagonists, a class of drugs, are widely used to treat elevated blood pressure by influencing calcium channels in vascular smooth muscle and cardiac cells. Clinical trials, such as the NORDIL study, have rigorously compared the efficacy of calcium antagonists against other antihypertensive agents, including diuretics and beta-blockers, in reducing cardiovascular morbidity and mortality in patients with hypertension. [10]
The findings from such trials are instrumental in guiding treatment selection, allowing clinicians to tailor pharmacological interventions based on patient profiles, comorbidities, and desired outcomes. The use of calcium antagonists exemplifies a targeted approach to managing cardiovascular disease, impacting long-term implications for patient health and quality of life by modulating key physiological processes.
References
[1] Wallace C et al. "Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia." Am J Hum Genet, 2008.
[2] Hunter D, De Lange M, Snieder H, MacGregor AJ, Swaminathan R, Thakker RV, Spector TD. "Genetic contribution to bone metabolism, calcium excretion, and vitamin D and parathyroid hormone regulation." J Bone Miner Res, vol. 16, 2001, pp. 371-378.
[3] O'Donnell CJ. "Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study." BMC Med Genet, 2007.
[4] Vasan, R. S., et al. "Genome-Wide Association of Echocardiographic Dimensions, Brachial Artery Endothelial Function and Treadmill Exercise Responses in the Framingham Heart Study." BMC Medical Genetics, vol. 8, 2007, p. 57.
[5] Hwang, S. J., et al. "A Genome-Wide Association for Kidney Function and Endocrine-Related Traits in the NHLBI's Framingham Heart Study." BMC Medical Genetics, vol. 8, 2007, p. 54.
[6] Benyamin, B., et al. "Variants in TF and HFE Explain Approximately 40% of Genetic Variation in Serum-Transferrin Levels." The American Journal of Human Genetics, vol. 84, no. 1, 2009, pp. 60-65.
[7] Yang, Q., et al. "Genome-Wide Association and Linkage Analyses of Hemostatic Factors and Hematological Phenotypes in the Framingham Heart Study." BMC Medical Genetics, vol. 8, 2007, p. 53.
[8] Benjamin EJ et al. "Genome-wide association with select biomarker traits in the Framingham Heart Study." BMC Med Genet, 2007.
[9] Gundberg, C. M., et al. "Osteocalcin: isolation, characterization, and detection." Methods Enzymol, vol. 107, 1984, pp. 516-544.
[10] Kathiresan, S., et al. "Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans." Nature Genetics, vol. 40, no. 2, 2008, pp. 189-197. PMID: 18193044.